A detailed history of Financial Advisory Service, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Advisory Service, Inc. holds 5,638 shares of LLY stock, worth $4.33 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
5,638
Previous 5,529 1.97%
Holding current value
$4.33 Million
Previous $5.01 Million 0.22%
% of portfolio
0.42%
Previous 0.46%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$772.14 - $960.02 $84,163 - $104,642
109 Added 1.97%
5,638 $4.99 Million
Q2 2024

Jul 29, 2024

BUY
$724.87 - $909.04 $67,412 - $84,540
93 Added 1.71%
5,529 $5.01 Million
Q1 2024

Apr 29, 2024

SELL
$592.2 - $792.28 $44,415 - $59,421
-75 Reduced 1.36%
5,436 $4.23 Million
Q4 2023

Jan 23, 2024

BUY
$525.19 - $619.13 $54,094 - $63,770
103 Added 1.9%
5,511 $3.21 Million
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $60,858 - $83,902
140 Added 2.66%
5,408 $2.9 Million
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $218,511 - $292,174
-623 Reduced 10.58%
5,268 $2.47 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $931 - $1,094
3 Added 0.05%
5,891 $2.02 Million
Q4 2022

Feb 01, 2023

SELL
$321.55 - $374.67 $2,250 - $2,622
-7 Reduced 0.12%
5,888 $2.15 Million
Q3 2022

Oct 20, 2022

BUY
$296.48 - $337.87 $281,656 - $320,976
950 Added 19.21%
5,895 $1.91 Million
Q2 2022

Aug 02, 2022

SELL
$278.73 - $327.27 $23,692 - $27,817
-85 Reduced 1.69%
4,945 $1.6 Million
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $938 - $1,166
4 Added 0.08%
5,030 $1.44 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $3,597 - $4,464
-16 Reduced 0.32%
5,026 $1.39 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $19,057 - $23,453
-86 Reduced 1.68%
5,042 $1.17 Million
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $722 - $934
4 Added 0.08%
5,128 $1.18 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $132,277 - $171,239
805 Added 18.64%
5,124 $957,000
Q4 2020

Feb 10, 2021

SELL
$130.46 - $172.63 $1,304 - $1,726
-10 Reduced 0.23%
4,319 $729,000
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $32,899 - $38,054
-225 Reduced 4.94%
4,329 $641,000
Q2 2020

Jul 21, 2020

SELL
$136.42 - $164.18 $26,465 - $31,850
-194 Reduced 4.09%
4,554 $748,000
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $476 - $589
4 Added 0.08%
4,748 $659,000
Q4 2019

Jan 31, 2020

BUY
$106.92 - $132.43 $11,868 - $14,699
111 Added 2.4%
4,744 $624,000
Q3 2019

Nov 06, 2019

BUY
$106.79 - $116.16 $320 - $348
3 Added 0.06%
4,633 $518,000
Q2 2019

Jul 25, 2019

BUY
$110.79 - $129.32 $332 - $387
3 Added 0.06%
4,630 $513,000
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $16,028 - $18,866
-144 Reduced 3.02%
4,627 $600,000
Q4 2018

Feb 08, 2019

SELL
$105.9 - $118.64 $21,391 - $23,965
-202 Reduced 4.06%
4,771 $552,000
Q3 2018

Nov 05, 2018

BUY
$85.86 - $107.31 $171 - $214
2 Added 0.04%
4,973 $534,000
Q2 2018

Jul 26, 2018

BUY
$75.7 - $86.88 $302 - $347
4 Added 0.08%
4,971 $424,000
Q1 2018

May 02, 2018

SELL
$74.21 - $87.6 $14,916 - $17,607
-201 Reduced 3.89%
4,967 $384,000
Q4 2017

Jan 29, 2018

SELL
$81.94 - $87.89 $26,384 - $28,300
-322 Reduced 5.87%
5,168 $436,000
Q3 2017

Oct 19, 2017

BUY
$77.07 - $85.54 $423,114 - $469,614
5,490
5,490 $470,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Financial Advisory Service, Inc. Portfolio

Follow Financial Advisory Service, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Service, Inc. with notifications on news.